Evidence map›Paper›PMID 23844022›Full record

ArticlePloS one2013

Oesophagostomum dentatum extract modulates T cell-dependent immune responses to bystander antigens and prevents the development of allergy in mice.

Irma Schabussova, Onisa Ul-Haq, Elisabeth Hoflehner, Johnnie Akgün, Angelika Wagner, Gerhard Loupal, Anja Joachim, Bärbel Ruttkowski, Rick M Maizels, Ursula Wiedermann

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Frontiers in immunology · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. DNA and mRNA vaccination against allergies.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2018
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Regulation of the host immune system by helminth parasites.The Journal of allergy and clinical immunology · 2016
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Allergy and worms: let's bring back old friends?Wiener medizinische Wochenschrift (1946) · 2014
    Review
  19. [MedUni Vienna Researcher of the Month, June 2014].Wiener klinische Wochenschrift · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Irma SchabussovaInstitute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria. irma.schabussova@meduniwien.ac.at
Onisa Ul-Haq
Elisabeth Hoflehner
Johnnie Akgün
Angelika Wagner
Gerhard Loupal
Anja Joachim
Bärbel Ruttkowski
Rick M Maizels
Ursula Wiedermann
Medical University of Vienna · ATUniversity of Veterinary Medicine Vienna · ATUniversity of Edinburgh · GB

Funding

Wellcome Trust 095831
6 · The paper itself

Abstract

One third of the human population is currently infected by one or more species of parasitic helminths. Certain helminths establish long-term chronic infections resulting in a modulation of the host's immune system with attenuated responsiveness to "bystander" antigens such as allergens or vaccines. In this study we investigated whether parasite-derived products suppress the development of allergic inflammation in a mouse model. We show that extract derived from adult male Oesophagostomum dentatum (eMOD) induced Th2 and regulatory responses in BALB/c mice. Stimulation of bone marrow-derived dendritic cells induced production of regulatory cytokines IL-10 and TGF-beta. In a mouse model of birch pollen allergy, co-administration of eMOD with sensitizing allergen Bet v 1 markedly reduced the production of allergen-specific antibodies in serum as well as IgE-dependent basophil degranulation. Furthermore, eMOD prevented the development of airway inflammation, as demonstrated by attenuation of bronchoalveolar lavages eosinophil influx, peribronchial inflammatory infiltrate, and mucus secretion in lungs and IL-4 and IL-5 levels in lung cell cultures. Reduced secretion of Th2-related cytokines by birch pollen-re-stimulated splenocytes and mesenteric lymph node cells was observed in eMOD-treated/sensitized and challenged mice in comparison to sensitized and challenged controls. The suppressive effects of eMOD were heat-stable. Immunization with model antigens in the presence of eMOD reduced production of antibodies to thymus-dependent but not to thymus-independent antigen, suggesting that suppression of the immune responses by eMOD was mediated by interference with antigen presenting cell or T helper cell function but did not directly suppress B cell function. In conclusion, we have shown that eMOD possesses immunomodulatory properties and that heat-stable factors in eMOD are responsible for the dramatic suppression of allergic responses in a mouse model of type I allergy. The identification and characterization of parasite-derived immune-modulating molecules might have potential for designing novel prophylactic/therapeutic strategies for immune-mediated diseases.

Indexed as

ImmunomodulationAllergensAnimalsAntigens, PlantBasophilsBystander EffectComplex MixturesDendritic CellsHumansHypersensitivityImmunity, InnateImmunoglobulin EInterleukin-10MaleMiceMice, Inbred BALB CAllergensAntigens, PlantBet v 1 allergen, BetulaComplex MixturesImmunoglobulin EInterleukin-10Transforming Growth Factor beta

Identifiers

PMID23844022
PMCPMC3699627
OpenAlexW2098142446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.